JENNIFER LEONARD: Open Payments
NPI 1649538463 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$197 in 10 payments from 5 companies in 2025. Trend: 2023 $275 · 2024 $178 · 2025 $197
Food & beverage: $197
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $49 |
| Gilead Sciences, Inc. | 2 | $42 |
| Aimmune Therapeutics, Inc. | 2 | $42 |
| GENZYME CORPORATION | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
Products named: DUPIXENT, RINVOQ, ENTYVIO, ZENPEP, VOWST, MAVYRET.
Industry payments across ID — which companies pay providers there.
